Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial

HIGHLIGHTS

• who: Meg J Jardine et al. from the , hospital sites in India have published the research work: Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial, in the Journal: (JOURNAL) of 16/09/2022
• what: This group assisted the trial steering committee, providing advice and feedback on trial aims, design, participant facing materials, and conduct.
• how: The authors conducted a randomised controlled trial featuring sample size adaptation sequential analyses and prespecified decision rules for futility and effectiveness with an aim to establish evidence on the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.